224 related articles for article (PubMed ID: 33839583)
1. Synthesis, in vitro evaluation, and molecular docking studies of novel hydrazineylideneindolinone linked to phenoxymethyl-1,2,3-triazole derivatives as potential α-glucosidase inhibitors.
Shareghi-Boroujeni D; Iraji A; Mojtabavi S; Faramarzi MA; Akbarzadeh T; Saeedi M
Bioorg Chem; 2021 Jun; 111():104869. PubMed ID: 33839583
[TBL] [Abstract][Full Text] [Related]
2. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of tetracyclic oxindoles and evaluation of their α-glucosidase inhibitory and glucose consumption-promoting activity.
Hao L; Ma Y; Zhao L; Zhang Y; Zhang X; Ma Y; Dodd RH; Sun H; Yu P
Bioorg Med Chem Lett; 2020 Jul; 30(14):127264. PubMed ID: 32527562
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li X; Li J
Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem Lett; 2016 Dec; 26(23):5719-5723. PubMed ID: 27810241
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
[TBL] [Abstract][Full Text] [Related]
7. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
[TBL] [Abstract][Full Text] [Related]
9. Cyanoacetohydrazide linked to 1,2,3-triazole derivatives: a new class of α-glucosidase inhibitors.
Iraji A; Shareghi-Brojeni D; Mojtabavi S; Faramarzi MA; Akbarzadeh T; Saeedi M
Sci Rep; 2022 May; 12(1):8647. PubMed ID: 35606520
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors.
Saeedi M; Mohammadi-Khanaposhtani M; Asgari MS; Eghbalnejad N; Imanparast S; Faramarzi MA; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Med Chem; 2019 Dec; 27(23):115148. PubMed ID: 31679980
[TBL] [Abstract][Full Text] [Related]
11. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies.
Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M
Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B
Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and in vitro study of densely functionalized oxindoles as potent α-glucosidase inhibitors.
Luthra T; Naga Lalitha K; Agarwal R; Uma A; Sen S
Bioorg Med Chem; 2018 Oct; 26(18):4996-5005. PubMed ID: 30153956
[TBL] [Abstract][Full Text] [Related]
14. Flavone-1,2,3-triazole derivatives as potential α-glucosidase inhibitors: Synthesis, enzyme inhibition, kinetic analysis and molecular docking study.
Dhameja M; Kumar H; Kurella S; Uma A; Gupta P
Bioorg Chem; 2022 Oct; 127():106028. PubMed ID: 35868105
[TBL] [Abstract][Full Text] [Related]
15. New carbazole linked 1,2,3-triazoles as highly potent non-sugar α-glucosidase inhibitors.
Iqbal S; Khan MA; Javaid K; Sadiq R; Fazal-Ur-Rehman S; Choudhary MI; Basha FZ
Bioorg Chem; 2017 Oct; 74():72-81. PubMed ID: 28756277
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of α-glucosidase enzyme by 'click'-inspired pharmacophore framework 1,3,4-thiadiazole-1,2,3-triazole hybrids.
Dhameja M; Kumar H; Kurella S; Singh R; Uma A; Gupta P
Future Med Chem; 2023 Feb; 15(4):345-363. PubMed ID: 36942781
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 1H-1,2,3-triazole derivatives as new α-glucosidase inhibitors and their molecular docking studies.
Avula SK; Khan A; Rehman NU; Anwar MU; Al-Abri Z; Wadood A; Riaz M; Csuk R; Al-Harrasi A
Bioorg Chem; 2018 Dec; 81():98-106. PubMed ID: 30118991
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro and computational studies of 1,4-disubstituted 1,2,3-triazoles as potential α-glucosidase inhibitors.
Jabeen F; Shehzadi SA; Fatmi MQ; Shaheen S; Iqbal L; Afza N; Panda SS; Ansari FL
Bioorg Med Chem Lett; 2016 Feb; 26(3):1029-1038. PubMed ID: 26725952
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro evaluation and molecular docking studies of novel amide linked triazolyl glycoconjugates as new inhibitors of α-glucosidase.
Gupta SJ; Dutta S; Gajbhiye RL; Jaisankar P; Sen AK
Bioorg Chem; 2017 Jun; 72():11-20. PubMed ID: 28346871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
